Emergent BioSolutions
EBS
#8033
Rank
$0.37 B
Marketcap
$7.22
Share price
-0.55%
Change (1 day)
18.95%
Change (1 year)

Emergent BioSolutions (EBS) - Total assets

Total assets on the balance sheet as of March 2026 : $1.32 Billion USD

According to Emergent BioSolutions 's latest financial reports the company's total assets are $1.32 Billion USD. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Emergent BioSolutions - Total assets on balance sheet (from 2004 to 2026)

Total assets by year

Year Total assets Change
2025-12-31$1.31 B-5.12%
2024-12-31$1.38 B-23.78%
2023-12-31$1.82 B-42.42%
2022-12-31$3.16 B7.05%
2021-12-31$2.95 B2.58%
2020-12-31$2.88 B23.89%
2019-12-31$2.32 B4.39%
2018-12-31$2.22 B108.32%
2017-12-31$1.07 B10.32%
2016-12-31$0.97 B-6.49%
2015-12-31$1.03 B10.52%
2014-12-31$0.93 B49.8%
2013-12-31$0.62 B11.06%
2012-12-31$0.56 B3.18%
2011-12-31$0.54 B9.3%
2010-12-31$0.50 B45.15%
2009-12-31$0.34 B18.54%
2008-12-31$0.29 B6.32%
2007-12-31$0.27 B14.8%
2006-12-31$0.23 B137.47%
2005-12-31$0.10 B45.29%
2004-12-31$69.05 M
2002-12-31$22.79 M-10.36%
2001-12-31$25.42 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Pfizer
PFE
$207.61 B 15,623.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$128.68 B 9,645.91%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
$83.25 B 6,205.60%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
$6.92 M-99.48%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
$0.21 B-83.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
$0.51 B-61.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$40.04 B 2,932.41%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel